0001209191-23-006354.txt : 20230202 0001209191-23-006354.hdr.sgml : 20230202 20230202180831 ACCESSION NUMBER: 0001209191-23-006354 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230131 FILED AS OF DATE: 20230202 DATE AS OF CHANGE: 20230202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brockstedt Dirk G. CENTRAL INDEX KEY: 0001635616 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38997 FILM NUMBER: 23582710 MAIL ADDRESS: STREET 1: C/O ADURO BIOTECH, INC. STREET 2: 740 HEINZ AVENUE CITY: BERKELEY STATE: CA ZIP: 94710 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RAPT Therapeutics, Inc. CENTRAL INDEX KEY: 0001673772 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473313701 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 489-9000 MAIL ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FLX Bio, Inc. DATE OF NAME CHANGE: 20160504 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-31 0 0001673772 RAPT Therapeutics, Inc. RAPT 0001635616 Brockstedt Dirk G. C/O RAPT THERAPEUTICS, INC. 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Scientific Officer Employee Stock Option (right to buy) 29.05 2023-01-31 4 A 0 56000 0.00 A 2033-01-30 Common Stock 56000 56000 D 1/48th of the shares subject to the option shall vest on each monthly anniversary of the vesting commencement date of January 1, 2023. /s/ Rodney Young, Attorney-in-Fact for Dirk G Brockstedt 2023-02-02